Asia Pacifics Demand for IT and Business Services Slows in Q2, ISG Index Shows
Despite 16% growth in cloud ACV, the combined market was down slightly…
Majority of Global Employers Remain Unprepared for Pay Transparency Laws, Aon Finds
Organizations remain focused on compliance rather than embracing transparency as a strategic…
Xinhua Silk Road: Ningxia goji berries claim over 61 pct of China’s online retail sales market in 2024
BEIJING, July 11, 2025 /PRNewswire/ -- The online retail sales value of goji…
2025 Kia Telluride ranks number one in its segment in J.D. Power 2025 U.S. Initial Quality Study (IQS)
Kia’s Award-Winning Three-Row SUV Earns Top Spot in Upper Midsize SUV Segment2025…
Kia Announces June 2025 Global Sales Results
June 2025 global sales of 269,652 units, up 0.2% Y/yOutside of Korea,…
Kia America Posts Highest FirstHalf Sales in Company History
416,511 units sold in first six months of 2025, up 8 percent…
Aon’s 2025 Global Cyber Risk Report Reveals Reputation Risk Events Can Reduce Shareholder Value by 27 percent
DUBLIN, June 17, 2025 /PRNewswire/ --Â Aon plc (NYSE: AON), a leading global…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
XRP News: Vaultro Finance Presale on XRP Ledger Sells Past 48% of Its Native Token Allocation Act Now Before It Sells Out
SINGAPORE, June 14, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has once again…